Jump to content
IndiaDivine.org

[drugawareness] IRELAND DEMANDS GLAXO TO RECALL PAXIL!!!

Rate this topic


Guest guest

Recommended Posts

atracyphd wrote:

 

My Groups | drugawareness Main Page

 

Ireland has just requested that GlaxoSmithKline recall Paxil in that country

because it failed to warn of suicidal behavior connected to the drug. Finally a

country willing to stand up for those being slaughtered by this company with

this deadly drug!!!! Obviously the Irish Medicines Board has far more integrity

than the FDA in this country.

 

For years I have warned that this is one of the most powerful and most deadly of

the SSRI antidepressants, the Prozac family of drugs, because of its strong

effect upon the reuptake of serotonin. How anyone can even take it is beyond me

considering the horrific headaches it causes as you begin to take the drug.

 

This is wonderful news! The BBC's wonderful piece on Paxil this Sunday, called

the Secrets of Seroxat [Paxil in the US], exposed much that has been hidden for

15 years about this drug and indicated that much is still being kept from the

public. If you have not seen the show yet I would highly recomend it and

encourage you to come to our site at www.drugawareness.org to access the show

online and view this excellent expose on Paxil.

 

Dr. Ann Blake Tracy, Executive Director,

International Coalition For Drug Awareness

www.drugawareness.org and author of Prozac: Panacea or Pandora? - Our Serotonin

Nightmare (800-280-0730)

 

 

http://quote.bloomberg.com/fgcgi.cgi?mnu=news & ptitle=Top%20Stories%20Europe &

tp=ad_uknews & T=news_storypage99.ht & ad=euro & s=APa1yWxaJR2xheG9T

 

Top Stories Europe

10/16 15:06

 

GlaxoSmithKline Told to Recall Antidepressant Drug in Ireland

 

By Thomas Molloy

 

Dublin, Oct. 16 (Bloomberg) -- Ireland told GlaxoSmithKline Plc to recall one of

its most prescribed drugs because a patient leaflet for the Irish market fails

to warn about possible suicidal behavior, the Irish Medicines Board said.

 

The U.K. pharmaceuticals company has been ordered to recall all stocks of the

antidepressant drug Seroxat stored by wholesalers, the board said.

 

The Irish Medicines Board, which controls the sale of medicines in Ireland,

asked GlaxoSmithKline to change the leaflets at the end of 2001. Glaxo responded

by adding new wording warning patients that suicidal thoughts may increase in

the first few weeks of treatment, the board said.

 

The Brentford, England-based company has now been told to ``revise the wording

on the license and patient information leaflets to include a reference to

suicidal behavior and depression,'' the board said in the statement.

 

Shares in GlaxoSmithKline fell 19 pence, or 1.4 percent, to 1,357p at 3:04 p.m.

local time in London.

 

Seroxat, also known as Paxil, is one of GlaxoSmithKline's most prescribed drugs,

with sales of $2.7 billion last year. It's part of a class of treatments known

as selective serotonin re- uptake inhibitors, which the U.S. Food and Drug

Administration doesn't consider habit-forming.

 

Last year, a jury in federal court in Wyoming said Glaxo should pay $6.4 million

to the relatives of a man who went on a shooting rampage, killing his family and

then himself after taking Seroxat. At the time, Glaxo said it would appeal.

 

Martin Sutton, a spokesman for GlaxoSmithKline in London, declined to comment,

saying the company would issue a statement later today.

 

 

 

 

 

 

 

 

 

Link to comment
Share on other sites

Yes, but think of all the people in Ireland who are addicted to Paxil, and

who will now have major withdrawal effects from the recall. It isn't just

it's potential side effects for suicide, but the fact that many people find

it impossible to withdraw from, and although the pharmaceutical companies

have covered that up, it's been uncovered through litigation. So what will

happen with all the Paxil addicts?

 

Linda Jones

lindaj

 

-

" Frank " <califpacific

<gettingwell >

Wednesday, October 16, 2002 6:43 PM

Re: [drugawareness] IRELAND DEMANDS GLAXO TO RECALL

PAXIL!!!

 

 

>

>

> atracyphd wrote:

>

> My Groups | drugawareness Main Page

>

> Ireland has just requested that GlaxoSmithKline recall Paxil in that

country because it failed to warn of suicidal behavior connected to the

drug. Finally a country willing to stand up for those being slaughtered by

this company with this deadly drug!!!! Obviously the Irish Medicines Board

has far more integrity than the FDA in this country.

>

> For years I have warned that this is one of the most powerful and most

deadly of the SSRI antidepressants, the Prozac family of drugs, because of

its strong effect upon the reuptake of serotonin. How anyone can even take

it is beyond me considering the horrific headaches it causes as you begin to

take the drug.

>

> This is wonderful news! The BBC's wonderful piece on Paxil this Sunday,

called the Secrets of Seroxat [Paxil in the US], exposed much that has been

hidden for 15 years about this drug and indicated that much is still being

kept from the public. If you have not seen the show yet I would highly

recomend it and encourage you to come to our site at www.drugawareness.org

to access the show online and view this excellent expose on Paxil.

>

> Dr. Ann Blake Tracy, Executive Director,

> International Coalition For Drug Awareness

> www.drugawareness.org and author of Prozac: Panacea or Pandora? - Our

Serotonin Nightmare (800-280-0730)

>

>

>

http://quote.bloomberg.com/fgcgi.cgi?mnu=news & ptitle=Top%20Stories%20Europe &

tp=ad_uknews & T=news_storypage99.ht & ad=euro & s=APa1yWxaJR2xheG9T

>

> Top Stories Europe

> 10/16 15:06

>

> GlaxoSmithKline Told to Recall Antidepressant Drug in Ireland

>

> By Thomas Molloy

>

> Dublin, Oct. 16 (Bloomberg) -- Ireland told GlaxoSmithKline Plc to recall

one of its most prescribed drugs because a patient leaflet for the Irish

market fails to warn about possible suicidal behavior, the Irish Medicines

Board said.

>

> The U.K. pharmaceuticals company has been ordered to recall all stocks of

the antidepressant drug Seroxat stored by wholesalers, the board said.

>

> The Irish Medicines Board, which controls the sale of medicines in

Ireland, asked GlaxoSmithKline to change the leaflets at the end of 2001.

Glaxo responded by adding new wording warning patients that suicidal

thoughts may increase in the first few weeks of treatment, the board said.

>

> The Brentford, England-based company has now been told to ``revise the

wording on the license and patient information leaflets to include a

reference to suicidal behavior and depression,'' the board said in the

statement.

>

> Shares in GlaxoSmithKline fell 19 pence, or 1.4 percent, to 1,357p at 3:04

p.m. local time in London.

>

> Seroxat, also known as Paxil, is one of GlaxoSmithKline's most prescribed

drugs, with sales of $2.7 billion last year. It's part of a class of

treatments known as selective serotonin re- uptake inhibitors, which the

U.S. Food and Drug Administration doesn't consider habit-forming.

>

> Last year, a jury in federal court in Wyoming said Glaxo should pay $6.4

million to the relatives of a man who went on a shooting rampage, killing

his family and then himself after taking Seroxat. At the time, Glaxo said it

would appeal.

>

> Martin Sutton, a spokesman for GlaxoSmithKline in London, declined to

comment, saying the company would issue a statement later today.

>

>

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...